Phase 4 Completed N=53 Treatment

Stereotaxis Study To Obliterate Persistent Ventricular Tachycardia

Ventricular Tachycardia

Source: ClinicalTrials.gov NCT00851279 ↗

Enrolled (actual)

Serious AEs

0.0%

Results posted

Aug 2015

Primary outcomePrimary: Percentage of Participants Free From VT at 1 Year Post-Treatment — 62 percentage of participants free from VT

Summary

This is a prospective, non-randomized, multi-center clinical case series evaluating the outcomes of the magnetic navigation system in ventricular tachycardia (VT) cases. Subjects will be evaluated acutely and will be followed clinically at 1, 6 and 12 months post-treatment.

Outcome Measures

Outcome	Result	p-value
PRIMARY Percentage of Participants Free From VT at 1 Year Post-Treatment	62	—

Eligibility Criteria

Inclusion Criteria

Subject must be between the ages of 18 - 80 years
Willing to provide prior written informed consent per local ethics committee guidelines
Subjects must present with ventricular tachycardia, characterized by: history of myocardial scar and spontaneous ventricular tachycardia
Able to be safely exposed to static magnetic fields
No in-situ devices are present or any in-situ devices have been verified to be compatible to magnetic fields

Exclusion Criteria

Presence of a mobile ventricular thrombus
Inability to access the left ventricle
Subjects must not have any contraindications to short-term anticoagulation
Subjects must not have a life expectancy of <1 year due to a medical illness

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT00851279). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.